{"source": "The New York Times", "lead_paragraph": "Not yet two years after serving time for insider trading, Samuel Waksal is again making deals.", "keywords": [{"value": "Waksal, Samuel", "rank": "1", "is_major": "N", "name": "persons"}, {"value": "ImClone Systems Inc", "rank": "2", "is_major": "N", "name": "organizations"}, {"value": "Kadmon Pharmaceuticals", "rank": "3", "is_major": "N", "name": "organizations"}, {"value": "Three Rivers Pharmaceuticals", "rank": "4", "is_major": "N", "name": "organizations"}], "multimedia": [{"width": 600, "url": "images/2010/11/01/business/jp-waksal/jp-waksal-articleLarge.jpg", "subtype": "xlarge", "height": 350, "type": "image", "legacy": {"xlargeheight": "350", "xlargewidth": "600", "xlarge": "images/2010/11/01/business/jp-waksal/jp-waksal-articleLarge.jpg"}}, {"width": 75, "url": "images/2010/11/01/business/jp-waksal/jp-waksal-thumbStandard.jpg", "subtype": "thumbnail", "height": 75, "type": "image", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/11/01/business/jp-waksal/jp-waksal-thumbStandard.jpg", "thumbnailwidth": "75"}}], "snippet": "Not yet two years after serving time for insider trading, Samuel Waksal is again making deals.", "print_page": "1", "blog": [], "headline": {"main": "ImClone Ex-Chief Embarks on New Biotech Venture", "seo": "Ex-Con Samuel Waksal Starts New Drug Venture", "print_headline": "ImClone Ex-Chief Embarks on New Biotech Venture"}, "_id": "541c408f38f0d8296cb10c3f", "web_url": "http://www.nytimes.com/2010/11/01/business/01waksal.html", "slideshow_credits": null, "byline": {"person": [{"organization": "", "rank": 1, "role": "reported", "lastname": "POLLACK", "firstname": "Andrew"}], "original": "By ANDREW POLLACK", "contributor": ""}, "news_desk": "Business", "word_count": "1438", "document_type": "article", "type_of_material": "News", "abstract": null, "pub_date": "2010-11-01T00:00:00Z", "subsection_name": null, "section_name": "Business Day"}